Source: SensCure
Date: Aug. 25, 2022
Views: 4,483
Recently, the innovative endoscopic clipping device independently developed by SensCure Biotech (Ningbo) Co., Ltd. received market approval from the Zhejiang Medical Products Administration (Registration No.: Zhejiang Xie Zhu Zhun 20222020390). The product entered the Special Approval Channel for Class II Innovative Medical Devices in Zhejiang Province in November 2019.
The endoscopic clipping device is indicated for endoscopic-guided closure of soft tissue defects, perforations, or hemorrhage within the digestive tract. It comprises four components: a release device, an applicator cap, the clipping device itself, and a wire hook. The clipping device is constructed from nitinol and medical-grade stainless steel wire, featuring a detachable design. Compared with conventional titanium clips, this product offers a broader closure range and superior clamping force, demonstrating extensive and significant clinical value.


